PNC-28

Research

1Vendor

Another p53-derived oncology peptide investigated for cancer-cell killing. It sits squarely in the research-only lane, with far more preclinical intrigue than consumer wellness use.

View Vendors

Studies
PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo.	PubMed
The penetratin sequence in the anticancer PNC-28 peptide causes tumor cell necrosis rather than apoptosis of human pancreatic cancer cells.	PubMed
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells.	PubMed

PNC-28 Vendors
Paramount Peptides 0.0	Profile

PNC-28 Vendors